Coya Therapeutics, Inc.COYANASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-10.29M
↓ 55% below average
Average (4y)
$-6.63M
Historical baseline
Range
High:$-391266.00
Low:$-11.19M
CAGR
+126.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-10.29M | +8.0% |
| 2023 | $-11.19M | -54.6% |
| 2022 | $-7.24M | -79.2% |
| 2021 | $-4.04M | -932.6% |
| 2020 | $-391266.00 | - |